Citi Research has maintained “buy” ratings on Abbott, Dexcom, Medtronic, and Insulet, citing continued growth in insulin pump use ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE